VTGN Stock Analysis: Buy, Sell, or Hold?
VTGN - Vistagen Therapeutics, Inc. Common Stock
$0.58
0.02 (3.82%)
▲
5d:
-7.18%
30d:
-12.45%
90d:
-84.55%
HOLD
LOW Confidence
Last Updated: February 2, 2026
Earnings: Feb 12, 2026
9d
Get Alerted When VTGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VTGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VTGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VTGN is currently trading at $0.58, which is considered oversold relative to its 30-day fair value range of $0.63 to $0.72.
Technical Outlook: Technically, VTGN is in a strong downtrend. Immediate support is located at $0.54, while resistance sits at $0.68. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: VTGN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $0.97 (+66.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VTGN is in a strong downtrend. Immediate support is located at $0.54, while resistance sits at $0.68. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: VTGN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $0.97 (+66.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.63 -
$0.72
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.8%)
- BULLISH: Trading 66.8% below Wall St target ($0.97)
- CAUTION: Recommendation downgraded due to -7.2% 5-day decline
Fair Price Analysis
30-Day Fair Range
$0.63 -
$0.72
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.54
Resistance Level
$0.68
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.47
Wall Street Target
$0.97
(+66.8%)
Revenue Growth (YoY)
41.0%
Last updated: February 02, 2026 4:15 PM ET
Data refreshes hourly during market hours. Next update: 5:15 PM
Data refreshes hourly during market hours. Next update: 5:15 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VTGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$477 | 50 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$514 | 63 BUY |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 48 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 62 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$847 | 54 HOLD |
